A View LCS vs Viz RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Coreline Soft
VS
by Viz.ai

AI Verdict

Tool A provides comprehensive thoracic CT analysis for lung cancer screening, emphysema quantification, and coronary artery calcification detection from low-dose CTs. Tool B, on the other hand, specializes in automating RV/LV ratio measurements from CTPA scans for rapid pulmonary embolism risk stratification. While both leverage AI for thoracic imaging analysis with cardiac relevance, Tool A focuses on broader screening and chronic disease assessment, whereas Tool B targets acute pulmonary embolism management.

Choose A View LCS if…

Choose A View LCS if your clinical practice requires a comprehensive, multi-disease analysis from a single low-dose thoracic CT scan, encompassing detailed lung cancer screening, emphysema quantification, and coronary artery calcification scoring. This tool is ideal for proactive screening programs that benefit from automated, detailed quantification and reporting across multiple chronic thoracic conditions.

View A View LCS →

Choose Viz RV/LV if…

Choose Viz RV/LV if your priority is rapid and automated risk stratification for suspected pulmonary embolism, specifically by obtaining crucial RV/LV ratio measurements from CTPA scans. This tool is best suited for emergency and acute care settings where immediate identification of ventricular strain and seamless integration into a broader pulmonary embolism care coordination workflow are critical for timely patient management.

View Viz RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature A View LCS Viz RV/LV
Deployment Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker). It can also be integrated into standard reading environments (PACS), RIS (Radiological Information System), or used as a standalone third-party application or web-based application. Cloud-based
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz RV/LV

Viz RV/LV (Tool B) excels in usability by focusing on real-time clinical workflows, offering AI-powered alerts, a high-fidelity mobile DICOM viewer, and a HIPAA-compliant communication platform for seamless care coordination. Its emphasis on immediate actionability and integrated team communication, supported by dedicated customer success and 24/7 support, streamlines critical care pathways. While A View LCS (Tool A) provides comprehensive reporting and 3D visualization, Tool B's features are more directly aligned with enhancing the day-to-day operational efficiency and responsiveness of care teams.

Clinical Value

A View LCS

A View LCS (Tool A) offers superior clinical value through its comprehensive thoracic CT analysis, detecting lung cancer, emphysema, and coronary artery calcification from a single low-dose CT scan. This multi-disease detection capability maximizes diagnostic efficiency and provides a broader range of critical insights from one examination. In contrast, Viz RV/LV (Tool B) is highly specialized, focusing on a single measurement for pulmonary embolism risk stratification, which, while important, is narrower in scope.

Pricing & Value

Tie

Both A View LCS (Tool A) and Viz RV/LV (Tool B) require prospective customers to contact the vendor for pricing information, indicating a lack of public transparency. Without specific pricing details or publicly available comparative ROI studies for either product, it is impossible to definitively assess or compare their pricing and overall value propositions.

Enterprise Readiness

A View LCS

A View LCS (Tool A) demonstrates greater enterprise readiness due to its flexible deployment options, including cloud-based, hybrid, local dedicated hardware, and local virtualized solutions. This versatility allows it to integrate more seamlessly into diverse IT infrastructures and accommodate varying data governance requirements of healthcare organizations. While Viz RV/LV (Tool B) is FDA-cleared, HIPAA compliant, and boasts extensive security certifications and a large customer base, its cloud-only deployment may not suit all enterprise needs.

Innovation

A View LCS

A View LCS (Tool A) showcases innovation with its 'CT kernel conversion AI technology,' which standardizes image analysis across different CT acquisition parameters, and its ability to perform comprehensive multi-disease analysis from a single low-dose CT scan. This addresses fundamental challenges in imaging consistency and diagnostic efficiency. While Viz RV/LV (Tool B) innovates in care coordination and workflow optimization with features like AI-powered alerts and Viz Agent Studio, Tool A's core imaging analysis advancements are more foundational.

Support & Docs

Viz RV/LV

Viz RV/LV (Tool B) offers a more robust and transparent support framework, including 24/7/365 urgent phone support, a dedicated customer success team, a comprehensive Help Center, and a 'Viz Academy' for user training. This extensive support ecosystem ensures continuous assistance and user enablement. While Coreline Soft (Tool A) provides customer service contacts and expert consultations, Viz.ai's multi-channel, round-the-clock support and educational resources demonstrate a stronger commitment to ongoing user support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature A View LCS Viz RV/LV
Name A View LCS Viz RV/LV
Company Coreline Soft Co. Viz.ai
Description AVIEW LCS by Coreline Soft is an FDA-cleared AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. Viz RV/LV by Viz.ai is an FDA-cleared AI algorithm that automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution.
Categories Cardiology AI, Oncology AI, Radiology & Imaging AI Cardiology AI, Clinical Decision Support & Reference, Radiology & Imaging AI
Specialties Cardiology, Pulmonology, Radiology Emergency Medicine, Pulmonology, Radiology
Key Features Automated lung nodule detection and classification; Nodule volume quantification and measurement (3D); Lung-RADS scoring and reporting; Emphysema analysis and quantification (LAA); Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass); Segmentation of major coronary arteries; Automated comprehensive report generation (PDF, DICOM PDF, SR); CT kernel conversion AI technology Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement; Analysis of volumetric CTPA acquisitions; AI algorithm for identification and measurement of heart ventricles; Provides annotated images showing ventricular measurements; Seamless component of the Viz PE Solution for suspected pulmonary embolism detection; AI-powered alerts and notifications to care teams; High-fidelity mobile DICOM image viewer; HIPAA-compliant communication platform for care coordination

Videos

Demos, reviews, and walkthroughs featuring A View LCS and Viz RV/LV.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AVIEW LCS is designed for comprehensive thoracic CT analysis, including lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. Viz RV/LV, on the other hand, automates right and left ventricular diameter measurements from CTPA scans to provide an RV/LV ratio for rapid pulmonary embolism risk stratification.
AVIEW LCS offers automated lung nodule detection and classification, nodule volume quantification, Lung-RADS scoring, emphysema analysis (LAA), and coronary artery calcium (CAC) scoring (Agatston, volume, mass), along with segmentation of major coronary arteries. Viz RV/LV specifically provides automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurements and identifies and measures heart ventricles from volumetric CTPA acquisitions.
AVIEW LCS generates automated comprehensive reports in PDF, DICOM PDF, and SR formats. Viz RV/LV is a seamless component of the Viz PE Solution, which includes AI-powered alerts and notifications to care teams, and a HIPAA-compliant communication platform for care coordination.
AVIEW LCS performs comprehensive thoracic CT analysis from a single low-dose CT scan. Viz RV/LV automates measurements from CTPA scans and analyzes volumetric CTPA acquisitions.
AVIEW LCS is designed for Cardiology, Pulmonology, and Radiology specialties. Viz RV/LV is primarily for Emergency Medicine, Pulmonology, and Radiology.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.